Global Tissue Diagnostics Market 2016-2020

February 24, 2016
This global market research segments the tissue diagnostics market by technology (advanced staining, digital pathology, and pre-analytical and routine staining), by product (consumables and instruments), by end user (hospitals, CROs, and academia and research institutes), and by geography (Americas, APAC, and EMEA). The prominent vendors analyzed in this market study report are Abbott Diagnostics, Agilent Technologies, Danaher, and Roche Diagnostics.

Overview of the global tissue diagnostics market

Technavio’s market research analyst has estimated the global market for tissue diagnostics to post an impressive CAGR of almost 12% by 2020. Rising prevalence of chronic diseases, such as colorectal, lung, liver, breast, cervical, and brain cancers, malaria, diabetes, and cardiovascular diseases will necessitate the need for effective tissue diagnostic procedures during the forecast period. Furthermore, with the augmented use of biomarkers for disease diagnosis, the global market for tissue diagnostics will have a positive outlook until the end of 2020. Biomarkers help to evaluate the pharmacological, physiological, and disease processes and are widely used for various clinical studies in the areas of proteomics, genomics, transcriptomics, and metabolomics. The ability of biomarkers to aid in the determination of disease prognosis, elucidation of pathways affected by the disease and identification of individuals that are likely to respond to specific therapeutic interventions will result in its augmented utilization during the predicted period.

In terms of geography, the Americas will be the largest market for tissue diagnostics during the forecast period. Due to the rapidly evolving diagnostic technologies, vendors can develop innovative tissue diagnostic products. These products help in the efficient validation of results of patient samples. During the forecast period, a rise in the public’s awareness will compel vendors to develop innovative products that will receive the FDA’s approval. The launch of such products during the estimated period will lead to the steady growth of this market. Extensive market research carried out by the analysts at Technavio has shown that the market for tissue diagnostics in the Americas will grow impressively at a CAGR of around 12% until 2020.

Technological segmentation of the tissue diagnostics market

  • Advanced staining
  • Digital pathology
  • Pre-analytical and routine staining

In this market research and analysis, the analysts have estimated the digital pathology sector to be the largest market segment during the forecast period. Digital pathology is also known as virtual pathology or virtual microscopy and involves the organization, analysis, and interpretation of digital information. The ability of this technology to allow high resolution, better interpretation, and analysis of the digital pathology images will lead to this segment’s impressive CAGR of nearly 16% during the predicted period.

Competitive landscape and key vendors

The global tissue diagnostics market is consolidated with the presence of many global players. To gain more market shares, the vendors focus on the instrumentation of IHC and ISH technologies, and also offer a comprehensive range of reagents that help research institutions in sample analysis in the therapeutic areas ranging from infectious diseases to cancers. Local players compete with global vendors based on product pricing and by offering systems with universal reagent analysis characteristics.

The top vendors in this market are -

  • Abbott Diagnostics
  • Agilent Technologies
  • Danaher
  • Roche Diagnostics

Other prominent vendors analyzed in this market study are 20/20 GeneSystems, Abcam, AdnaGen, Advanced Cell Diagnostics, Affymetrix, Agendia, AutoGenomics, AVIVA BioSciences, Biocare Medical, Biocartis, Cancer Genetics, ELITechGroup, Enzo Biochem, Epic Sciences, Fluidigm, HORIBA Medical, Janssen Diagnostics, Olympus Diagnostics Systems Group, Omnyx (a joint venture of GE Healthcare and the University of Pittsburgh Medical Center, US), Oxford Gene Technology, PANAGENE, Protea Biosciences Group, and Sakura Finetek.

Product-based segmentation of the tissue diagnostics market

  • Instruments
  • Consumables

The consumables product segment dominated this market during 2015 and is anticipated to further enhance its hold over the market by 2020 owing to the rising demand for tissue diagnostics for the effective diagnosis of various diseases like cancer. According to this segmentation analysis, the consumables segment will account for more than 69% of the total market share by 2020.

Key questions answered in the report include

  • What will the market size and the growth rate be in 2020?
  • What are the key factors driving the tissue diagnostics market?
  • What are the key market trends impacting the growth of the tissue diagnostics market?
  • What are the challenges to market growth?
  • Who are the key vendors in the tissue diagnostics market?
  • What are the market opportunities and threats faced by the vendors in the tissue diagnostics market?
  • Trending factors influencing the market shares of the Americas, APAC, and EMEA.
  • What are the key outcomes of the five forces analysis of the tissue diagnostics market?

Technavio also offers customization on reports based on specific client requirement.

Related reports